High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high‐risk ewing sarcoma family tumors
暂无分享,去创建一个
R. Cozza | A. Jenkner | A. Donfrancesco | R. Boldrini | C. Dominici | A. Inserra | M. De Ioris | L. de Sio | I. Ilari | G. Milano